top of page
Search
Glenn Hearson
Aug 15, 2022
Impact of ELX/TEZ/IVA on Patients With Cystic Fibrosis (TRAJECTORY)
We have recently commenced a new study in conjunction with with Vertex Pharmaceuticals Incorporated and Cardiff and Vale University...
46
Glenn Hearson
Jun 30, 2022
COMPAIR: A Comparison of Clinic-based Versus Home-based Spirometry, Study Now Fully Completed
Our multi-site clinical research trial to assess spirometry tests performed in our research centre to ‘remote’ spirometry tests that...
124
Glenn Hearson
May 4, 2022
APEX-3; to improve our understanding of what is happening during suspected asthma attacks
We will shortly commence recruitment for our 3rd asthma attack study as part of our APEX research. This 3rd APEX study, will be...
163
Glenn Hearson
Mar 3, 2022
To better understand asthma attacks; The APEX Study
To better understand asthma attacks; The APEX Study
215
Glenn Hearson
Feb 22, 2022
Understanding Patient Priorities for Scientific Research on COPD
Dr Amanda Tatler and Dr Rachel Clifford , along with many other researchers in Translational Medical Science at the University of...
195
Glenn Hearson
Nov 1, 2021
Beyond Allergic Th2 Severe Asthma (BEAT-SA) Trial
We will shortly be commencing a new clinical research trial #BEAT-SA. Beyond Allergic Th2 Severe Asthma (BEAT-SA) #BEAT-SA is a...
246
Glenn Hearson
Oct 15, 2021
A potential new medicine for severe asthma the #SWIFT-1 Study
We will shortly be commencing recruitment into a new asthma trial sponsored by GlaxoSmithKline (GSK) called SWIFT-1 A 52-week,...
298
Glenn Hearson
Oct 15, 2021
A potential new medicine for severe asthma the #NIMBLE Study
A potential new medicine for severe asthma the #NIMBLE Study
362
bottom of page